Healthcare -
Biotechnology - NASDAQ - US
$ 13.55
0 %
$ 196 M
Market Cap
0.11
P/E
INBX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity INBX - Inhibrx Biosciences, Inc.
308 M
LAST VALUE
43.06%
2 YEAR CAGR
98.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR